Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2019-04-10 Director's Dealing
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
108年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on insider shareholdings and pledges, with no financial statements or earnings data. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is 3356 characters, which is sufficient for such a report. There is no indication of other report types such as financial results, governance changes, or voting results. Therefore, the document is best classified as a Director's Dealing report.
2019-04-10 Chinese
108年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document contains financial data related to guarantees and endorsements, with specific monetary amounts and periods (month and previous month). It is a short document (616 characters) and appears to be a regulatory disclosure of financial information rather than a full financial report. There is no indication of it being an annual or quarterly report, audit report, or other detailed filings. It is a typical regulatory announcement of financial data disclosures, fitting best under Regulatory Filings (RNS).
2019-04-10 Chinese
108年3月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summarized revenue report for a company named 杏輝 for the period 民國108年03月 (March 2019). It contains monthly and cumulative net operating revenue figures, percentage changes compared to the previous year, and notes on accounting standards (IFRS) application. The document is very short (767 characters) and primarily provides financial summary data without detailed financial statements or analysis. It does not appear to be a full annual or interim report, nor an earnings release with key highlights. It is more of a brief financial summary or factsheet. Given the length and content, it fits best as a Fund Information / Factsheet (FS) type document, which is a brief summary of key company financials and market info.
2019-04-10 Chinese
107年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data table showing key financial ratios and metrics for three consecutive fiscal years (105年度, 106年度, 107年度) for the company 杏輝. The data includes financial structure, debt ratios, liquidity ratios, operational efficiency, profitability, and cash flow metrics. The document is relatively short (1007 characters) and presents summarized financial data over multiple years, but it does not contain full financial statements or detailed analysis typical of an Annual Report (10-K) or Interim Report (IR). It appears to be a brief financial data summary or factsheet provided by the company. Given the concise nature and summary format, the best fitting category is Fund Information / Factsheet (FS).
2019-04-01 Chinese
107年第4季海外子公司投資
Regulatory Filings Classification · 90% confidence The document is a tabular disclosure of investment holdings and investment income/losses related to overseas subsidiaries for a specific quarter (107年4季, which corresponds to Q4 of the 107th year in the Taiwanese calendar, roughly 2018). It includes detailed financial figures such as original investment amounts, ending investment balances, and recognized investment gains or losses. The document is relatively short (1075 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is also not a meeting material, call transcript, or governance document. Given the nature of the data and the context, this fits best as a Regulatory Filing (RNS) because it is a general regulatory disclosure of investment information that does not fit into other specific categories.
2019-04-01 Chinese
107年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning the company's investments in mainland China. It includes specific financial data such as capital amounts, investment gains or losses, and cumulative investment figures. The document is relatively short (1499 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report. There is no indication that this is an annual or quarterly report, audit report, or earnings release. It is not a meeting material or voting result. The content fits best with a regulatory filing that provides specific investment disclosures as required by authorities. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-04-01 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.